Stefan Galluppi - 22 Aug 2025 Form 4 Insider Report for LifeMD, Inc. (LFMD)

Role
Chief Innovation Officer
Signature
/s/ Stefan Galluppi
Issuer symbol
LFMD
Transactions as of
22 Aug 2025
Net transactions value
$0
Form type
4
Filing time
26 Aug 2025, 18:18:06 UTC
Previous filing
17 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Galluppi Stefan Chief Innovation Officer C/O LIFEMD, INC, 236 FIFTH AVENUE, SUITE 400, NEW YORK /s/ Stefan Galluppi 26 Aug 2025 0001722649

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFMD Common Stock Award $0 +30,000 +37% $0.000000 110,449 22 Aug 2025 Direct F1
holding LFMD Common Stock 1,644,800 22 Aug 2025 By American Nutra Tech, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of performance stock which vested on August 22, 2025